• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Evidence for selective reporting of analyses & discrepancies in clinical trials: a systematic review

Dolphin

Senior Member
Messages
17,567
Possibly of interest to the odd person interested in methodological issues

Free full text: http://dx.plos.org/10.1371/journal.pmed.1001666

PLoS Med. 2014 Jun 24;11(6):e1001666. doi: 10.1371/journal.pmed.1001666. eCollection 2014.
Evidence for the selective reporting of analyses and discrepancies in clinical trials: a systematic review of cohort studies of clinical trials.

Dwan K1, Altman DG2, Clarke M3, Gamble C1, Higgins JP4, Sterne JA5, Williamson PR1, Kirkham JJ1.

Abstract

BACKGROUND:

Most publications about selective reporting in clinical trials have focussed on outcomes.

However, selective reporting of analyses for a given outcome may also affect the validity of findings.

If analyses are selected on the basis of the results, reporting bias may occur.

The aims of this study were to review and summarise the evidence from empirical cohort studies that assessed discrepant or selective reporting of analyses in randomised controlled trials (RCTs).

METHODS AND FINDINGS:

A systematic review was conducted and included cohort studies that assessed any aspect of the reporting of analyses of RCTs by comparing different trial documents, e.g., protocol compared to trial report, or different sections within a trial publication.

The Cochrane Methodology Register, Medline (Ovid), PsycInfo (Ovid), and PubMed were searched on 5 February 2014.

Two authors independently selected studies, performed data extraction, and assessed the methodological quality of the eligible studies.

Twenty-two studies (containing 3,140 RCTs) published between 2000 and 2013 were included.

Twenty-two studies reported on discrepancies between information given in different sources.

Discrepancies were found in statistical analyses (eight studies), composite outcomes (one study), the handling of missing data (three studies), unadjusted versus adjusted analyses (three studies), handling of continuous data (three studies), and subgroup analyses (12 studies).

Discrepancy rates varied, ranging from 7% (3/42) to 88% (7/8) in statistical analyses, 46% (36/79) to 82% (23/28) in adjusted versus unadjusted analyses, and 61% (11/18) to 100% (25/25) in subgroup analyses.

This review is limited in that none of the included studies investigated the evidence for bias resulting from selective reporting of analyses.

It was not possible to combine studies to provide overall summary estimates, and so the results of studies are discussed narratively.

CONCLUSIONS:

Discrepancies in analyses between publications and other study documentation were common, but reasons for these discrepancies were not discussed in the trial reports.

To ensure transparency, protocols and statistical analysis plans need to be published, and investigators should adhere to these or explain discrepancies.

PMID:

24959719